Andere Sprachen Amphastar Pharmaceuticals, Inc.

Aktien

A11664

US03209R1032

AMPH

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 07.05.2024			% 5 Tage	% 1. Jan.
42,77 ^USD	+0,21 %		+3,68 %	-30,85 %

01.05.	HINTERGRUND/FTC knöpft sich Patentanmeldungen für Arzneimittel vor	DJ
30.04.	FTC beanstandet 'Junk'-Patentlisten für Ozempic, Victoza und andere Medikamente	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

FTC Challenging 'Junk' Patent Listings for Ozempic, Victoza, Other Medications	30.04.
Top Midday Stories: Shares of Eli Lilly, HSBC Get Post-Earnings Bump; BBVA Exploring Merger With Sabadell; FTC Disputes 300 'Junk' Patent Listings	30.04.
FTC Challenging 'Junk' Patent Listings for Ozempic, Victoza, Other Medications	30.04.
FTC Challenging 'Junk' Patent Listings for Ozempic, Victoza, Other Medications	30.04.
FTC Challenging 'Junk' Patent Listings for Ozempic, Victoza, Other Medications	30.04.
Amphastar Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference	02.04.
Amphastar Pharmaceuticals Insider Sold Shares Worth $842,883, According to a Recent SEC Filing	08.03.
Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended December 31, 2023	29.02.
Sector Update: Health Care Stocks Advance Premarket Thursday	29.02.
Amphastar Pharmaceuticals Q4 Adjusted Earnings, Revenue Rise	29.02.
Amphastar Pharmaceuticals, Inc. Reports Impairment of Long-Lived Assets for the Fourth Quarter Ended December 31, 2023	28.02.
Amphastar Pharmaceuticals, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	28.02.
Amphastar: Q4 Earnings Snapshot	28.02.
Earnings Flash (AMPH) AMPHASTAR PHARMACEUTICALS Posts Q4 EPS $0.88, vs. Street Est of $0.91	28.02.
Earnings Flash (AMPH) AMPHASTAR PHARMACEUTICALS Reports Q4 Revenue $178.1M, vs. Street Est of $173.3M	28.02.
Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 28, 2024	21.02.
High-dose opioid reversal spray no better than lower dose in field, US study finds	08.02.
Amphastar Pharmaceuticals Insider Sold Shares Worth $7,171,768, According to a Recent SEC Filing	11.01.
Amphastar Pharmaceuticals Insider Sold Shares Worth $12,798,708, According to a Recent SEC Filing	11.01.
Amphastar Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference	03.01.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Amphastar Pharmaceuticals, Inc.

Aktien

A11664

US03209R1032

AMPH

Andere Sprachen

Filter